The Roche Investor Relations team would like to invite you to the Roche Pharma Day that will take place in London on Monday, 30 September 2024, starting at 09:00 BST and will finish at 14:30 BST with a reception.

The Roche Pharma Day will address the following topics:

 

  • Group strategy / Pharma strategy / R&D Excellence
  • Commercial growth drivers
  • Pipeline updates
    • Oncology solid tumors / Hematology, Neurology, Ophthalmology, Immunology, Cardiovascular and Metabolism
 

Presenters will include:

  • Thomas Schinecker, CEO Roche Group
  • Teresa Graham, CEO Roche Pharmaceuticals
  • Levi Garraway, EVP, Head of Product Development and Chief Medical Officer
  • Charles Fuchs, SVP, Global Head of Hematology and Oncology Product Development
  • Azad Bonni, SVP, Global Head of Neurology & Rare Diseases pRED
  • Larry Tsai, SVP, Global Head of Immunology Product Development
  • Christopher Brittain, SVP, Global Head of Ophthalmology Product Development
  • Manu Chakravarthy, SVP, Global Head of Cardiovascular, Renal and Metabolism (CVRM) Product Development
 


You will have the opportunity to meet senior management during the event.

Meeting information: 
Date/Time (BST):
Monday, 30 September 2024
09:00 Registration
09:30 Event starts
14:30 Event ends, followed by refreshments with the Roche Management Team

Venue
etc.venues St Paul’s
200 Aldersgate
London EC1A 4HD
map

Registration has closed, please contact investor.relations@roche.com.

The slides will be available for download at 8:30 BST on the day of the event.
> click here

 

Alternatively you may participate virtually in the webinar (no access to speakers, pre-registration required). Please pre-register for the webinar here*.

 

Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com .

 

A replay of the event will be available via > ir.roche.com
*privacy notice

 

Best regards,

 

 
Bruno Eschli
Head of Investor Relations

 

 
 
 
 
 
Roche Investor Relations 
Dr. Bruno Eschli
Phone: +41 61 68-75284
e-mail: bruno.eschli@roche.com

 
Dr. Sabine Borngräber
Phone: +41 61 68-88027
e-mail: sabine.borngraeber@roche.com

 
Dr. Birgit Masjost
Phone: +41 61 68-84814
e-mail: birgit.masjost@roche.com

 
 
 
 
Investor Relations North America 
Loren Kalm
Phone: +1 650 225 3217
e-mail: kalm.loren@gene.com
 

get the latest news and updates to your inbox.